Investigation of the Effects of Functionalized Fiber Tissue Scaffolds on an In Vitro Demyelination Model
Project no. 28487 · Status: Kapanmış (Yayın bekleniyor) · 2023
Summary
<p>Spinal cord injury (SCI) is a severe and debilitating condition with no current effective treatment. Therapeutics used in the clinic are still at an early stage in terms of successfully repairing damaged tissues and achieving full functional recovery. Regenerative strategies such as cell transplantation for tissue damage, injection of growth factors, and the use of biomaterials and stem cells have been ongoing for many years. SCI is a condition caused by mechanical and traumatic effects, leading to damage in resident central nervous system (CNS) cells such as neurons, astrocytes, and oligodendrocytes (OLs).</p><p></p><p>Damage to these cells disrupts neuronal connections, triggers inflammation, and leads to demyelination; however, remyelination fails to occur. As a result, the metabolic support normally provided by myelin sheaths to axons is lost, leading to progressive axonal and neuronal degeneration. Remyelination is a neuroprotective process and represents both an effective therapeutic strategy for diseases that impose a significant economic burden on society and a critical area of research on its own. Ongoing research in SCI includes pharmacological treatments, cell transplantation therapies, gene therapy, and tissue engineering approaches.</p><p></p><p>Recent advances in biotechnology have enabled the development of experimental studies in the field of spinal cord regeneration. From a therapeutic perspective, partial functional recovery in spinal cord injury may be achieved through the combination of several treatment strategies, leading to improvements in patients’ quality of life. Polymeric tissue scaffolds have long been used in biomaterial-based approaches through functionalization.</p><p></p><p>As a novel therapeutic approach, a biomaterial-based treatment option functionalized by incorporating CRISPR/Cas9 complexes into injectable hydrogels has been validated to induce <em>in vitro</em> myelination.</p><p></p><p>As remyelination-inducing agents, ADAM8-KO and SERPINE1-KO CRISPR/gRNAs, which are expected to have effects on myelin, were used. While ADAM8-KO application did not significantly affect the expression of inflammation-related genes in oligodendrocytes, it showed a limited myelin-supportive effect, reflected only by an increase in MBP gene expression. In contrast, SERPINE1-KO increased the expression of all major myelin-related genes (MBP, MOG, CNP), demonstrating that it promotes the formation of a more stable and remyelination-supportive microenvironment through extracellular matrix remodeling and the removal of degenerative factors.</p><p></p><p>This study contributes to the development of CRISPR/Cas9-based modulatory therapeutics aimed at reducing adverse effects on oligodendrocytes. As a novel therapeutic approach, hydrogels functionalized with SERPINE1-suppressing CRISPR/Cas9 exhibit remyelination potential.</p>